ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026
A reproducible and physiologically relevant human iPSC-derived platform for in vitro modeling of the neurocardiac junction.
Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Induced Pluripotent Stem Cell-Based Platforms for Cardiac-Related Pain Research: Molecular Mechanisms, Experimental Models, and Therapeutic Applications.International journal of molecular sciences · 2026Review
- Synergistic effects of nicotine and hyperlipidemia induce cardiac damage via dynamic cardiomyocyte-based biosensing.Microsystems & nanoengineering · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The cardiac autonomic nervous system is central to various cardiac diseases, yet its regulation in the human heart remains poorly understood due to the lack of reliable models. Here, we report the development of a neurocardiac co-culture system using human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and sympathetic neurons (hiPSC-SNs). Both cell types were characterized molecularly and electrophysiologically and subsequently used for the establishment of the co-culture model in a two-well chambers insert, forming a dense axonal network connected with hiPSC-CMs. The co-culture demonstrated robust functional interactions: hiPSC-CMs maintained a stable beating rate, while hiPSC-SNs exhibited significantly increased firing activity after 7 days. Nicotine stimulation enhanced hiPSC-SN activity, resulting in an increased beating rate in co-cultured hiPSC-CMs, an effect that is absent in monoculture. This rise in the beats was abolished by nicotinic acetylcholine receptor blockade through α-bungarotoxin on hiPSC-SNs in co-culture. The β-blocker propranolol mitigated isoproterenol or nicotine effects on hiPSC-CMs. Using a fluorescent tracer, functional exocytosis and norepinephrine release was confirmed in hiPSC-SNs in co-culture. This novel neurocardiac model replicates neuronal control of cardiomyocytes and provides a new and robust platform for studying neuro-cardiac interactions. It represents a promising tool for advancing disease modeling and pharmacologic research in cardiac pathophysiology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.